American Cancer Society, ACS, recommends that men age fifty and over discuss the benefits and risks of screening in order to make an informed decision with his provider (Wolf, Wender, Etzioni,….& Smith, 2010). ACS also recommends if a man is at a high risk, that this information is presented earlier than fifty (Wolf et al…2010). Those at a higher risk include African American men with a

he American Cancer Society, ACS, recommends that men age fifty and over discuss the benefits and risks of screening in order to make an informed decision with his provider (Wolf, Wender, Etzioni,….& Smith, 2010). ACS also recommends if a man is at a high risk, that this information is presented earlier than fifty (Wolf et al…2010). Those at a higher risk include African American men with a family history of prostate cancer occurring in a family member who is not elderly (Wolf et al…2010). ACS also does not recommend that men whose life expectancy is less than ten years be screened for prostate cancer (Wolf et al…2010). Providers need to provide men with the benefits of early detection and treatment with the risk factors of treatment for prostate cancer. The results of PSA testing are not conclusive and therefore, the ACS reiterates the importance of the patient having the knowledge and information to make an informed decision. The ACS provides educational brochures and handouts on PSA screening to help guide patients to a discussion of this subject with his provider.